NYU Langone Medical Center
New York, 10016, United States
NCT Number: NCT02588352
The current prospective cross-sectional pilot study is proposed to determine a set of characteristic factors associated with salt sensitivity in young adults by measuring blood pressure, serum aldosterone levels, urine analysis, arterial pulse wave velocity and central arterial pressure in response to short term increases in salt intake.
Looking for future studies?
Notify Me21 year–30 year
All sexes
Interventional
Not applicable
New York, 10016, United States
Since salt sensitivity at an early age is associated with subsequent hypertension and an increase in mortality, intervention by lifestyle modification including the reduction of sodium intake could prevent subsequent increases in blood pressure and development of hypertension, cardiovascular disease and death. It would therefore be beneficial to have a simple method of identifying salt sensitive young adults so that risk factor modification can be achieved to prevent progression of the effects of hypertension on heart function.
This study is a longitudinal pilot study to identify characteristics of salt sensitive young adults so that this population of people can be identified early on and appropriate lifestyle modifications can be made to prevent the subsequent progression of hypertension and cardiovascular disease.
The study will be conducted at 2 visits separated by one week. At the first visit, eligible subjects will be asked to complete questionnaires regarding childhood and current sodium intake.Subjects will be asked about family history of hypertension and cardiovascular disease. Subjects will also undergo blood pressure measurement in both arm, and will provide a blood sample and spot urine sample. Subjects will then be asked to take salt pills 3 times a day for one week, and then return to the study center for a repeat of the above measurements.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will be given salt tablets and instructed to take 4 grams of sale three times a day (total of 12 grams of salt/day) for one week
Time frame: Visit 1 (One Week)
Defined as an increase in mean arterial blood pressure greater than 5 mmHg
Time frame: Baseline to Visit 2 (One Week)
change in serum aldosterone level
Time frame: Baseline to Visit 2 (One Week)
Change in augmentation index determined by radial artery tonometry
NYU Langone Health
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07422298
Healthy Volunteers
San Antonio, Texas, United States
View Trial DetailsNCT07215299
Healthy Volunteers
Bloomington, Indiana, United States
View Trial DetailsNCT03113903
Anxiety Disorders, Behavior
Clermont-Ferrand, France
View Trial DetailsNCT07742137
Aging, Behavior
Seville, Spain
View Trial Details